Skip to main content
Log in

Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Study on the normal saline vs povidone–iodine mouthwashes for oral mucositis (OM) prophylaxis in patients after high-dose chemotherapy comprising bischloroethyl nitrosourea etoposide ara-C melphalan (BEAM) or high-dose melphalan (HD-L-PAM) followed by autologous peripheral stem cell transplantation indicated that females have higher a incidence of OM compared to men, as reported by [Vokurka et al. 13:554–558, (2005)]. The multivariable analysis of larger cohort of 148 patients compliant with the original study protocol confirmed female gender to be an independent risk factor and predictor for OM. The HD-L-PAM (200 mg/m2) conditioning regimen revealed to be more toxic compared to BEAM as for incidence of OM grades 3–4 World Health Organization score. Body mass index, age, mouthwash solution used, and CD34+ cell number in the autologous graft were verified not to have an impact on OM incidence in this group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Vokurka S, Bystricka E, Koza V et al (2005) The comparative effects of povidone–iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT—results of a randomized multicentre study. Support Care Cancer 13:554–558

    Article  PubMed  Google Scholar 

  2. Sonis S, Elting L, Keefe D et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025

    Article  PubMed  Google Scholar 

  3. Robien K, Schubert M, Bruemmer B et al (2004) Predictors of oral mucositis in patients receiving hematopoietic cell transplant for chronic myelogenous leukemia. J Clin Oncol 22:1268–1275

    Article  PubMed  Google Scholar 

  4. Raber-Durlacher JE, Weijl NI, Abu Saris M et al (2000) Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer 8(5):366–371

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We highly acknowledge the assistance of K. Steinerova, M.D., F.Šefrna, RNDr., I. Chvojková, V. Kaslová (Plzen), J. Vítková (Olomouc), J. Maslová (Hradec Králové), P. Horvathová, V. Jarolíková, R. Micheliová (Bratislava), J. Bocková (Kosice), A. Kalocayová, E. Karliková, S. Kerestenyová, S. Gyurkyová and S. Statianová (Bánská Bystrica).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samuel Vokurka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vokurka, S., Bystrická, E., Koza, V. et al. Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer 14, 974–976 (2006). https://doi.org/10.1007/s00520-006-0031-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-006-0031-z

Keywords

Navigation